Open to all ACG 2019 attendees, Exhibitor Theaters are provided by ACG exhibitors. These presentations provide additional educational opportunities for attendees. No CME is provided for Theater presentations.
SUNDAY, OCTOBER 27
Different Questions. Same Answer.
Eric J. Lawitz, MD
5:15 pm - 6:00 pm
This exhibitor product theater presentation is sponsored by Gilead Sciences, Inc.
Learn About Clinical Updates in the Management of Chronic Idiopathic Constipation (CIC)
6:15 pm - 7:00 pm
This program will discuss the efficacy and safety of a treatment option for adults with CIC, as well as the unmet need, trial design, mechanism of action, and dosing/administration.
This exhibitor product theater presentation is sponsored by Takeda Pharmaceuticals U.S.A., Inc.
MONDAY, OCTOBER 28
Treatments for the Proactive Management of IBS-D, IBS-C, and CIC: Featuring New Phase 3b Data for a Treatment for IBS-C
Phillip S. Schoenfeld, MD, MSEd, MScEpi, FACG
10:30 pm - 11:30 am
This exhibitor product theater presentation is sponsored by Allergan and Ironwood
Want to witness the unveiling of NEW STUDY RESULTS for STELARA®(ustekinumab)? Please join the Janssen Product Theater presentation by Miguel Regueiro, MD.
Miguel Regueiro, MD
12:45 pm - 1:20 pm
This exhibitor product theater presentation is sponsored by Janssen Biotech, Inc.
IBS-D: A Closer Look at Diagnosis, Microbial Imbalance, and a Short-Term Treatment Option
Baharak Moshiree, MD, FACG
1:40 pm - 2:15 pm
Dr. Baha Moshiree, Professor of Medicine and Director of Motility in the Division of Gastroenterology at the University of North Carolina in Charlotte, North Carolina (Atrium Health), will provide a closer look at IBS-D -Diagnosis, Microbial Imbalance, and a Short-Term Treatment Option.
Sponsored by Salix Pharmaceuticals
New Perspectives on Advanced Fibrosis Due to NASH (Non Alcoholic Steatohepatitis)
Naim Alkhouri, MD
3:45 pm - 4:45 pm
This exhibitor product theater presentation is sponsored by Intercept Pharmaceuticals.
TUESDAY, OCTOBER 29
Seeing The Unseen: Identifying Chronic Pancreatitis and Exocrine Pancreatic Insufficiency
Tyler Stevens, MD, MS, FACG
10:35 am - 11:30 am
Join us for a presentation exploring the complex nature of chronic pancreatitis (CP) etiology and discussing recent updates in the diagnosis of CP as well as exocrine pancreatic insufficiency (EPI) manifestation. Dr. Tyler Stevens, Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, will review the recently updated CP TIGAR-O etiology classification system and discuss the feasibility of early CP diagnosis. Additionally, he will explore the clinical consequences, diagnosis, and management of EPI, a common condition present in patients with CP.
This exhibitor theater presentation is sponsored by AbbVie
Discover more about clinical data and VARSITY— the first head-to-head trial of biologic therapies for moderate to severe ulcerative colitis (UC).
Asher Kornbluth, MD
12:45 pm - 1:20 pm
In this program, expert gastroenterologist Asher Kornbluth, MD, will discuss the mechanism of action and clinical profile of a therapeutic option for adult patients with moderate to severe UC.
This exhibitor theater presentation is presented by Takeda Pharmaceuticals U.S.A., Inc.
Current State of H. pylori Disease, Antibiotic Resistance and Research
William D. Chey, MD, FACG
1:40 pm - 2:15 pm
This presentation will cover the current disease state of H. pylori and the growing resistance to current antibiotic therapies. It will also explore new research regarding H. pylori therapy.
This educational theater presentation is sponsored by RedHill Biopharma, Inc.